At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 1,075 enrolled
Drug / intervention
Adapalene lotion 0.1% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared With Vehicle Lotion in Subjects With Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating Adapalene lotion 0.1% and Adapalene Lotion Vehicle for Acne Vulgaris. Completed, enrolled 1,075 participants across 34 sites in 2 countries.
Detailed Summary
The purpose of this study is to determine whether Adapalene, 0.1% is safe and effective in the treatment of Acne Vulgaris.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesCanada, United States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
First PostedJan 2008
Primary CompletionOct 2008
Study CompletionNov 2008
TodayJul 2026
First PostedJan 23, 2008
Enrollment StartNov 1, 2007
Primary CompletionOct 1, 2008
Study CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 18.4 years ago
Interventions
Adapalene lotion 0.1%drug
Adapalene, 0.1% will be applied topically to the face, once a day, for 12 weeks
Adapalene Lotion Vehicledrug
Adapalene Lotion Vehicle will be applied topically to the face, once a day, for 12 weeks